BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

18 hedge funds and large institutions have $7.28M invested in Biolase, Inc. in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
Archon Capital Management
Washington
$410K
2
TMC
2
Trellus Management Company
Florida
$143K
3
Citadel Advisors
3
Citadel Advisors
Florida
$13K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$13K
5
TSS
5
Two Sigma Securities
New York
$12K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$125K
2
BC
2
Birchview Capital
Vermont
$0
3
VF
3
Virtu Financial
New York
$0
4
TFO
4
Tarbox Family Office
California
$8K
5
Northern Trust
5
Northern Trust
Illinois
$31K
Name Market Value Shares Shares
Change 		Shares
Change %
Nordea Investment Management
26
Nordea Investment Management
Sweden
– – – –
HNB
27
Huntington National Bank
Ohio
– – – –
Bank of America
28
Bank of America
North Carolina
– – – –
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2